BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders Jan 15, 2021
BioCorRx Provides Business Update for the Third Quarter of 2020; BioCorRx Subsidiary, BioCorRx Pharmaceuticals Inc. Progressing with Pivotal Nonclinical BICX102 Study Nov 16, 2020
BioCorRx Partners with Truusight Health to Integrate Recovery Program Into Self-Funded Health Plans Oct 13, 2020
BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic May 22, 2020
BioCorRx Offers Free Access to the UnCraveRx™ Mobile Platform for Weight Loss Management During COVID-19 Pandemic Apr 10, 2020
BioCorRx Offers Free Access to the BioCorRx Recovery Program Mobile Platform for Medical Professionals During COVID-19 Pandemic Apr 7, 2020
BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic Mar 31, 2020
